Immunotherapy is a groundbreaking treatment modality that leverages the immune system to combat various diseases, primarily cancer. As advancements in this field continue to evolve, it is crucial for physicians to comprehend its principles and applications.
Immunotherapy, also known as biological therapy, involves the use of living organisms, substances derived from them, or synthetic versions to enhance or restore immune function. It can be categorized into active, passive, and hybrid forms based on the approach to stimulate the immune response.
Immunotherapy has revolutionized cancer treatment by offering targeted therapies with fewer side effects than traditional treatments. It works either by stimulating the immune system to attack cancer cells or by providing it with components, such as immune system proteins. Checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines are prime examples of this treatment.
Biomarkers play a pivotal role in predicting the response to immunotherapy. Common biomarkers include PD-L1 expression and microsatellite instability. Understanding these biomarkers can guide physicians in choosing the appropriate immunotherapy treatment for individual patients.
While immunotherapy has revolutionized cancer treatment, it is not devoid of side effects. These can range from mild fatigue to severe immune-related adverse events. Early recognition and management of these side effects are crucial to ensure patient safety and treatment efficacy.
Immunotherapy marks a new era in the fight against cancer and other diseases. As the field continues to evolve, physicians must stay abreast of the latest developments to provide the best possible care to their patients. Understanding the fundamentals of immunotherapy, its applications, and potential side effects is key to harnessing its full potential in clinical practice.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation